SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 76 filers reported holding SCPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $150 | -99.9% | 21 | -99.8% | 0.00% | – |
| Q2 2023 | $103,164 | +4209.3% | 10,124 | +3734.8% | 0.00% | – |
| Q1 2023 | $2,394 | +28.4% | 264 | +1.5% | 0.00% | – |
| Q4 2022 | $1,864 | -37.9% | 260 | -44.1% | 0.00% | – |
| Q1 2021 | $3,000 | -50.0% | 465 | -61.4% | 0.00% | – |
| Q4 2020 | $6,000 | +100.0% | 1,206 | +258.9% | 0.00% | – |
| Q3 2020 | $3,000 | -40.0% | 336 | -52.3% | 0.00% | – |
| Q2 2020 | $5,000 | -28.6% | 704 | -26.1% | 0.00% | – |
| Q1 2020 | $7,000 | +40.0% | 953 | +24.3% | 0.00% | – |
| Q3 2019 | $5,000 | +66.7% | 767 | -25.2% | 0.00% | – |
| Q2 2019 | $3,000 | -40.0% | 1,025 | -39.0% | 0.00% | – |
| Q1 2019 | $5,000 | -28.6% | 1,679 | -8.2% | 0.00% | – |
| Q4 2018 | $7,000 | -61.1% | 1,828 | -39.4% | 0.00% | – |
| Q3 2018 | $18,000 | +28.6% | 3,017 | +20.5% | 0.00% | – |
| Q2 2018 | $14,000 | -97.1% | 2,503 | -93.5% | 0.00% | – |
| Q1 2018 | $481,000 | – | 38,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |